Tag: Roche
Emcure Pharma and Roche sign dstribution agreement to strengthen nephrology &...
Under the agreement, which will be effective April 1, 2026, Emcure will distribute Roche’s established and globally recognised brands in the nephrology and transplant segment in India
Roche partners 10 govt hospitals to strengthen clinical trial capabilities in...
Initiative aligns with CDSCO priorities to boost participation of government sites in Phase 3 and 4 Trials
Roche Pharma India announces recipients of the 2nd Edition of LEAP...
Each winner was awarded INR 3 lakh scholarship, a certificate, and medal for their contributions to advancing academic excellence in oncology
LuNGS Alliance launches free lung NGS biomarker testing for lung cancer...
An Initiative by Cancer Research and Statistic Foundation, Supported by AstraZeneca, Pfizer & Roche and lab partner 4baseCare
Metropolis Healthcare launches high-risk HPV DNA testing for cervical cancer screening...
Achieves 100% concordance in verification of Self-Sampling HPV DNA test, aligning with WHO recommendations
Roche and Hitachi extend partnership for 10 more years
Extension of long-standing collaboration strengthens global diagnostics reach and healthcare solutions
Roche signs MoU with VinCense to augment access to diabetes care...
The programme drives integration of digital health solution to ensure early detection and continuum of care
Roche gets FDA approval for Alecensa in early lung cancer
This approval helps address an urgent unmet need, with about half of people living with early-stage NSCLC experiencing disease recurrence
Swiss healthcare company Roche inaugurates new campus for its Digital Centre...
The campus can accommodate nearly 1,300 professionals dedicated to working on the latest technologies relevant for our healthcare business
J&J acquisition of Ambrx bolsters cancer ADC portfolio amidst big pharma’s...
In 2022, the global ADC market for cancer treatment was valued at $7.5 billion, with Roche’s Kadcyla generating $2.2 billion, followed by Daiichi Sankyo’s Enhertu at $1.5 billion